Clinical trial Recruiting at 1 site Interventional Ages 18 to 44 Women only

WORTH Paths: digital support for women with substance use and contraception needs

Official title: Adaptation of a Digital Group-Based Intervention to Reduce Drug Use and Increase Contraceptive Use Among Reproductive-Aged Women Involved in Criminal Justice Systems

Run by Fairleigh Dickinson University · NCT06889831 · Data updated 2026-11-12

This study tests whether WORTH Paths, a brief digital group program, can help reproductive-aged women involved in the criminal legal system reduce drug use and increase use of contraception.

Quick facts

Study typeInterventional
Ages18 Years to 44 Years
SexWomen only
Enrollment50 (estimated)
SponsorFairleigh Dickinson University
Academic / other
Locations1 site (Teaneck, New Jersey)
StatusRecruiting
StartedAugust 12, 2025
Main results expectedSeptember 1, 2026
Study endsDecember 1, 2026
Registry record updatedMay 6, 2026
Trial IDNCT06889831 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking individuals assigned female at birth, aged 18–44, with past-year criminal legal involvement, a current DSM-5 substance use disorder, sexually active with an unmet need for contraception, and able to provide informed consent.

Probably not a fit

People who are currently pregnant or trying to conceive, have diagnosed infertility, cannot provide informed consent, or are unable or unwilling to attend virtual sessions are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

WORTH Paths is a digital adaptation of the evidence-based WORTH intervention, expanded to address a full range of contraceptive options alongside strategies to reduce substance use. In a randomized design, 50 participants will be assigned to the WORTH Paths intervention (three facilitated virtual group sessions) or an active wellness group, with feasibility, acceptability, and preliminary behavioral outcomes tracked over follow-up. Eligibility focuses on English-speaking people assigned female at birth, ages 18–44, with past-year criminal legal involvement, current DSM-5 substance use disorder, and an unmet need for contraception. The study measures changes in drug use and contraceptive uptake as well as participant engagement and satisfaction.

Why it matters

Potential benefit: If successful, the program could increase contraceptive use and reduce drug use by offering accessible, tailored digital group support for justice-involved women.

How similar studies have gone: The original WORTH intervention has demonstrated success increasing condom use, but this digital adaptation targeting broader contraceptive uptake plus substance use reduction is a novel approach with limited prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female sex at birth
* Aged 18-44 years
* Past year criminal legal involvement (e.g., incarceration or community supervision)
* Meets criteria for current substance use disorder (SUD) as defined by DSM-5 and assessed by the Mini-International Neuropsychiatric Interview (MINI)
* Meets criteria for unmet need for contraception (capable of pregnancy, sexually active, does not want to become pregnant within the next year, but is currently not using contraception)
* Able to read, write, and speak English
* Willing and able to provide informed consent

Exclusion Criteria:

* Currently pregnant or actively trying to conceive
* Diagnosed infertility (e.g., menopause, tubal ligation, hysterectomy)
* Unable to provide informed consent due to significant cognitive impairment, mental health condition, or substance intoxication
* Unable or unwilling to meet study requirements (e.g., attend sessions, complete assessments)

Where it's running

  • Fairleigh Dickinson University
    Teaneck, New Jersey, United States
    Recruiting

Study contacts

  • Principal investigator: Melissa N Slavin, PhD — Fairleigh Dickinson University
  • Study coordinator: Melissa N Slavin, PhD
  • Email: m.slavin@fdu.edu
  • Phone: 201-692-2301

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.